LDH: A Broad Marker of Tissue Damage

Introduction

Understanding lactate dehydrogenase and what elevated levels reveal about your health

LDH (lactate dehydrogenase) is one of the least understood—yet most informative—markers on a standard blood panel. This enzyme is found in nearly every cell in your body, particularly in the heart, liver, kidneys, muscles, and red blood cells. When tissues are damaged or dying, they release LDH into the bloodstream, making it a sensitive (though nonspecific) marker of cellular injury. Elevated LDH can signal anything from hemolysis (red blood cell breakdown) to liver disease, kidney damage, muscle injury, heart attack, infection, or even cancer. Because LDH elevation can stem from so many sources, it’s often overlooked or dismissed as insignificant. Yet LDH is valuable precisely because of this breadth: it serves as an early warning system that something is wrong and deserves investigation. This guide explores what LDH is, what causes elevation, and how to interpret it alongside other markers for comprehensive health assessment.

What Is LDH and Why Is It Found Everywhere?

LDH (lactate dehydrogenase) is an enzyme present in virtually every cell in your body. It catalyzes the interconversion of lactate and pyruvate in cellular energy metabolism, making it essential for the glycolytic pathway—the fundamental energy-generating process in all cells. Because LDH is so ubiquitous, cell damage from any source releases it into the bloodstream. A heart attack damages cardiac cells, releasing cardiac-specific LDH isoenzyme LD1. Hemolysis (red blood cell breakdown) releases LDH from dying RBCs. Liver disease damages hepatocytes and elevates LDH. Muscle injury from exercise, trauma, or rhabdomyolysis releases muscle LDH. Infections can elevate LDH through tissue inflammation and damage. Cancers often elevate LDH dramatically, particularly aggressive tumors with high cell turnover. This universal presence is both LDH’s strength and weakness: it’s sensitive to tissue damage (good for early detection) but nonspecific about the source (requires additional investigation to determine cause).

What Are Normal LDH Levels and What Does Elevation Mean?

What Causes LDH Elevation?

LDH elevation reflects tissue injury, but determining the source requires clinical context and additional testing. Cardiac causes include myocardial infarction (heart attack), myocarditis (heart inflammation), and heart failure. Hematologic causes include hemolytic anemia, massive transfusion, or sickle cell disease. Hepatic causes include viral hepatitis, cirrhosis, or hepatocellular carcinoma. Renal causes include acute kidney injury or chronic kidney disease. Muscle causes include rhabdomyolysis, trauma, or severe exercise. Infectious causes include severe infections like sepsis, pneumonia, or tuberculosis. Malignancy, particularly lymphoma, leukemia, and other aggressive cancers, often cause dramatic LDH elevation. Pulmonary causes include pulmonary embolism or acute respiratory distress syndrome. The breadth of possible causes is why isolated LDH elevation always requires investigation—rarely is it insignificant.

“LDH elevation is like a smoke detector in your body—it signals that a fire is burning somewhere, but doesn’t tell you where. Further investigation is always warranted.”

— American Journal of Clinical Pathology

How Does LDH Connect to Other Liver and Cardiovascular Markers?

LDH is often part of a broader metabolic panel that includes ALT and AST (liver enzymes), hemoglobin (red blood cell function), and bilirubin (red blood cell breakdown products). Together, these markers paint a picture of tissue health. If LDH and ALT are both elevated, liver damage is likely. If LDH is elevated with low hemoglobin and high bilirubin, hemolytic anemia is possible. If LDH is dramatically elevated with normal liver enzymes, malignancy or severe muscle damage may be occurring. Understanding why tracking lab results as interconnected patterns—rather than interpreting single markers—reveals the true meaning of LDH elevation and guides appropriate investigation. The power of early detection often depends on noticing LDH elevation before symptoms become severe.

LDH and Cancer: An Important Relationship

LDH is particularly elevated in certain cancers, especially hematologic malignancies (lymphoma, leukemia) and cancers with high cell turnover. LDH elevation in cancer reflects the rapid metabolism and cell death characteristic of malignant tumors. Elevated LDH in newly diagnosed cancer predicts worse prognosis. LDH is also used to monitor treatment response: if LDH falls after chemotherapy, treatment is working; if LDH remains elevated or rises, the cancer may be treatment-resistant. This makes LDH a valuable tool in both cancer detection (as part of screening for high-risk populations) and cancer management. However, LDH is not sensitive or specific enough to be used as a primary cancer screening tool—many benign conditions elevate LDH, and some cancers don’t. Rather, LDH is most useful when elevated in a context suggesting malignancy (constitutional symptoms, weight loss, lymphadenopathy) or in monitoring known cancer patients.

What Should You Do If Your LDH Is Elevated?

• Assess severity: Determine whether elevation is mild (280-500), moderate (500-1000), or severe (>1000). Severity guides urgency of investigation.
• Review symptoms: Do you have chest pain, shortness of breath, fatigue, weight loss, fever, or other constitutional symptoms? Context guides investigation.
• Check related markers: Test hemoglobin, liver enzymes (ALT, AST), bilirubin, kidney function, and cardiac markers (troponin, BNP) to narrow the differential diagnosis.
• Repeat testing: One elevated LDH can be a spurious result. Retest to confirm elevation is real, not a lab error.
• Investigate systematically: Based on context and related markers, pursue imaging, additional laboratory testing, or specialist referral as appropriate.

LDH is a warning signal, not a diagnosis. When elevated, it demands attention and investigation. By taking LDH elevation seriously and pursuing systematic investigation, you ensure that serious conditions like malignancy, heart disease, or severe hemolysis are caught early—when treatment is most effective.

Accuracy Caveat:

LDH reference ranges vary by laboratory, with typical normals between 140-280 U/L. Some specialized assays measure LDH isoenzymes, which provide more specificity about the tissue source of LDH elevation. Hemolysis during blood draw can falsely elevate LDH, so elevated results should be confirmed by repeat testing. LDH is not useful as a solitary screening tool but is valuable in the context of other clinical findings and biomarkers.